Description of anaphylactic reactions to paclitaxel and docetaxel reported to the FDA, with a focus on the role of premedication

Author： Raisch Dennis W   Campbell Wesley   Garg Vishvas   Qureshi Zaina P   Bookstaver P Brandon   Norris LeAnn B   Bennett Charles L  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.10, Iss.4, 2011-07, pp. : 521-528

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevention of Anaphylactic Reactions to Anaesthetic Drugs

By Fisher M.M.   Doig G.S.  

Drug Safety, Vol. 27, Iss. 6, 2004-01 ,pp. : 393-410

Adis International

Access to resources Recommend Favorite

Paclitaxel and docetaxel in the treatment of breast cancer

By Saloustros Emmanouel   Mavroudis Dimitris   Georgoulias Vassilis  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 15, 2008-10 ,pp. : 2603-2616

Informa Healthcare

Access to resources Recommend Favorite

Fibrin sealant: Anaphylactic reactions: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1194-1195, 2008-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite

Fluorescein: Anaphylactic reactions: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1203, 2008-01 ,pp. : 24-24

Adis International

Access to resources Recommend Favorite

Paclitaxel + carboplatin, docetaxel alone, for endometrial cancer

By  

Inpharma, Vol. 1, Iss. 1579, 2007-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite